CDC study reveals hybrid SARS-CoV-2 spike from Delta/Omicron recombination event
Sunday, May 15, 2022 10:57 AM
The US Centers for Disease Control and Prevention (CDC) has conducted national-level genomic surveillance to identify and characterize delta-omicron recombinant genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A total of nine genomes with a hybrid delta-omicron spike protein have been identified. The study is published in the journal Emerging Infectious Diseases. Read more.